Thanks to Silja Choquet (whydotpharma on Twitter), I learned about a post on Sally Church’s blog, Pharma Strategy Blog, focusing on social media “experts” who are providing incoherent or inappropriate advice to pharmaceutical companies about social media marketing strategy. She wrote:
“The other day I was talking to someone who described themselves (and their company) as a 'social media expert' and was looking to sell their services to Pharma companies wishing to use this channel for marketing their brands. Except that on asking for more information, their world was mostly confined to blogging, Twitter, Facebook and Google Analytics. Their response to which social bookmarks did they use got an airy, 'oh I don't bother with those, too time consuming.' What about showing them trend data about their brands? 'Twistori is way cool!' I couldn't even find them in LinkedIn. Their Pharma experience was virtually non-existent, judging by the blank look they gave me on being asked how they would address adverse event concerns with review teams.”
Wow.
The post has generated a significant amount of discussion around the blogosphere and Twitter. A lot of what she discusses makes sense and the comments are very insightful.
Speaking of people who know what they are talking about, I’ve been enjoying Jonathan Richman’s blog, Dose of Digital. His posts are spot on and very thought provoking. If you’re not reading his blog, you should. You’re guaranteed not to be disappointed.
.jpg)
Comment Preview